Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

304.61 +1.59 (+0.52%)
Official Closing Price Updated: 4:10 PM EDT, Aug 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,350,409
Open 304.50
Bid (Size) 303.01 (1)
Ask (Size) 304.60 (3)
Prev. Close 303.02
Today's Range 302.59 - 307.13
52wk Range 220.20 - 335.33
Shares Outstanding N/A
Dividend Yield 1.12%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently. 
Via MarketBeat
Topics ETFs
Exposures COVID-19
The 3 Best Vanguard Funds to Buy in August
VCR, VHT and VYM are among the best Vanguard funds to buy now. Here is why they will make great investments in the coming months. 
Via InvestorPlace

Performance

YTD
+12.10%
+12.10%
1 Month
-7.99%
-7.99%
3 Month
+6.62%
+6.62%
6 Month
+26.97%
+26.97%
1 Year
+14.02%
+14.02%

More News

Read More
The 7 Best Fidelity Funds for Retirees
Via InvestorPlace
Eli Lilly: Expected To Rise Towards Its Resistance Level At Around $320
Via Talk Markets
What Are Whales Doing With Eli Lilly
Via Benzinga
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review
Via Investor's Business Daily
Looking Into Eli Lilly's Recent Short Interest
Via Benzinga
Market Volatility Eases Further As Nasdaq Reaches New Three-Month High
Via Benzinga
U.S. Job Growth Might Slow To This Level In July, Here Are The Major Macro Issues For Friday
Via Benzinga
Pieris Stops Work On Cancer Med, Tested In Combo With Eli Lilly Drugs
Via Benzinga
Animal Spirits: Nasdaq Up 19% Off June Lows
Via Benzinga
A Flurry Of Employment News Drops Ahead Of Friday's Jobs Report
Via Benzinga
S&P 500, Nasdaq Digest Flurry Of Earnings As Jobs Report Looms Large
Via Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
Via Benzinga
Eli Lilly Slashes Guidance After 'Significantly' Missing Quarterly Estimates; Shares Dive
Via Investor's Business Daily
Eli Lilly Cuts Annual Profit Outlook After Q2 Earnings Miss; Plans To Begin Covid-19 Antibody Sale Commercially
Via Benzinga
U.S. Stock Futures Edge Higher Ahead of Jobless Claims Data
Via Benzinga
Alibaba, Eli Lilly And 3 Stocks To Watch Heading Into Thursday
Via Benzinga
Bitcoin Drops But Remains Above This Major Level, Here Are Other Crypto Movers That Should Be On Your Radar
Via Benzinga
Novo Nordisk's Obesity Sales Nearly Doubled, But That Wasn't Enough For NVO Stock
Via Investor's Business Daily
Equity Index Futures Rebound Despite Concerns Over OPEC And China
Via Benzinga
Omicron BA.4/5 Subvariants Are More Contagious And More Treatment-Resistant, But This Biopharma Reports Working On A Potential Breakthrough
Via Benzinga
U.S. Manufacturing Picture Is Looking Brighter Than Europe's Right Now
Via Benzinga
Publication Of Peer-Reviewed Study In Journal Of The Alzheimer's Association Could Mark A Significant Step For Longeveron
Via Benzinga
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.